A Study of Trastuzumab Emtansine in Patients With HER2-Positive Metastatic Breast Cancer and Normal or Reduced Hepatic Function

计划入组 28 人 · 首次发布于 2012 年 1 月 20 日

Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant Cancers

计划入组 131 人 · 首次发布于 2016 年 2 月 5 日

A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer Who Have Received Prior Anti-HER2 And Chemotherapy-based Treatment

计划入组 2,185 人 · 首次发布于 2012 年 10 月 8 日

Naratuximab emtansine

laprituximab emtansine

Trastuzumab emtansine(Kadcyla)

Rx

T-DM1 Shows Sustained Survival Benefit in HER2-Positive Breast Cancer

Prevalence and Profiles of Treatment-Related Adverse Events in Metastatic Breast Cancer Patients Receiving Antibody-Drug Conjugates

Next-Generation ADCs and SERDs Transform Breast Cancer Treatment Landscape